Literature DB >> 1335332

Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs.

S G Farmer1, D E Wilkins, S A Meeker, E A Seeds, C P Page.   

Abstract

1. We examined effects of bradykinin (BK) receptor antagonists on airway hyperresponsiveness and eosinophilia in sensitized guinea-pigs that had been administered single, as well as repeated (chronic) challenges with inhaled ovalbumin. In addition, the effects of BK antagonists on antigen-induced respiratory distress during the chronic study were noted. 2. At 24 h following single antigen challenge, guinea-pigs exhibited airway hyperresponsiveness to the bronchoconstrictor effect of i.v. histamine, characterized by a left shift in the dose-response curve. In addition, responses to the maximum dose of histamine that could be used were significantly increased in hyperresponsive guinea-pigs. The percentages of bronchoalveolar fluid, eosinophil and neutrophils also increased. 3. A BK B1 receptor antagonist, desArg9-[Leu8]-BK, significantly inhibited airway hyperresponsiveness induced by single antigen challenge. A B2 receptor antagonist, D-Arg-[Hyp3, Thi5,8,D-Phe7]-BK (NPC 349) had a small, but statistically significant inhibitory effect on responsiveness to the highest histamine dose in challenged animals. DesArg9-[Leu8]-BK significantly inhibited the neutrophilia, whereas NPC 349 inhibited infiltration by both cell types. 4. Chronic antigen challenge also caused airway hyperresponsiveness to i.v. acetylcholine (ACh), distinguished by an increase in the slope of the dose-response curve. Thus, the magnitude of the bronchoconstrictor responses to the maximum dose of ACh that could be used was significantly increased. No change in sensitivity to ACh was evident. Marked eosinophilia was also noted in the trachea, bronchi and lung parenchyma. 5. Airway hyperresponsiveness and eosinophilia, induced by chronic antigen challenge, were markedly inhibited by the B2 antagonists, D-Arg-[Hyp3,D-Phe7]-BK (NPC 567) or D-Arg-[Hyp3,Thi5d-Tic7,Tic8]-BK (NPC 16731).NPC 16731 also abolished antigen-induced cyanosis, and delayed the onset of dyspnoea,doubling the time taken for animals to exhibit respiratory distress.6. The ability of BK receptor antagonists to inhibit antigen-induced airway hyperresponsiveness, in addition to eosinophilia, indicates an important role for endogenous kinins. Moreover, the abrogation of eosinophil infiltration suggests that BK has a significant function in maintaining allergic inflammation of the airways.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335332      PMCID: PMC1907780          DOI: 10.1111/j.1476-5381.1992.tb14502.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Induction of vascular smooth muscle bradykinin B1 receptors in vivo during antigen arthritis.

Authors:  S G Farmer; B A McMillan; S N Meeker; R M Burch
Journal:  Agents Actions       Date:  1991-09

2.  Autoradiographic visualization of bradykinin receptors in human and guinea pig lung.

Authors:  J C Mak; P J Barnes
Journal:  Eur J Pharmacol       Date:  1991-02-26       Impact factor: 4.432

3.  D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors.

Authors:  S G Farmer; R M Burch; D J Kyle; J A Martin; S N Meeker; J Togo
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

Review 4.  Bronchial hyperreactivity.

Authors:  H A Boushey; M J Holtzman; J R Sheller; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1980-02

5.  Airway effects of inhaled bradykinin, substance P, and neurokinin A in sheep.

Authors:  W M Abraham; A Ahmed; A Cortes; M Soler; S G Farmer; L E Baugh; S L Harbeson
Journal:  J Allergy Clin Immunol       Date:  1991-02       Impact factor: 10.793

6.  Repeated antigen challenge induces airway hyperresponsiveness with tissue eosinophilia in guinea pigs.

Authors:  K Ishida; L J Kelly; R J Thomson; L L Beattie; R R Schellenberg
Journal:  J Appl Physiol (1985)       Date:  1989-09

7.  Airway hyperreactivity follows anaphylactic microshock in anaesthetized guinea-pigs.

Authors:  L Daffonchio; A N Payne; I W Lees; B J Whittle
Journal:  Eur J Pharmacol       Date:  1989-02-28       Impact factor: 4.432

8.  Nedocromil sodium inhibits airway hyperresponsiveness and eosinophilic infiltration induced by repeated antigen challenge in guinea-pigs.

Authors:  R R Schellenberg; K Ishida; R J Thomson
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

9.  Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects.

Authors:  S C Christiansen; D Proud; C G Cochrane
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

10.  Release of kallikrein from guinea pig lung during anaphylaxis.

Authors:  O Jonasson; E L Becker
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

View more
  12 in total

1.  Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats.

Authors:  C Bandeira-Melo; A S Calheiros; P M Silva; R S Cordeiro; M M Teixeira; M A Martins
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Effects of selective phosphodiesterase inhibitors on platelet-activating factor- and antigen-induced airway hyperreactivity, eosinophil accumulation, and microvascular leakage in guinea pigs.

Authors:  J L Ortiz; J M Vallés; M Martí-Cabrera; J Cortijo; E J Morcillo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

3.  Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.

Authors:  P J Turner; J W Dear; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

4.  Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice.

Authors:  Jadranka Eric; Bichoy H Gabra; Pierre Sirois
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines.

Authors:  S Koyama; E Sato; H Nomura; K Kubo; M Miura; T Yamashita; S Nagai; T Izumi
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

6.  Modelling the electrophysiological endothelial cell response to bradykinin.

Authors:  Alexander Schuster; Jean-Louis Bény; Jean-Jacques Meister
Journal:  Eur Biophys J       Date:  2003-02-20       Impact factor: 1.733

7.  Differential effects of B2 receptor antagonists upon bradykinin-stimulated phospholipase C and D in guinea-pig cultured tracheal smooth muscle.

Authors:  S Pyne; N J Pyne
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Bradykinin stimulates MMP-2 production in guinea pig tracheal smooth muscle cells.

Authors:  Ewa Zaczynska; Bichoy H Gabra; Pierre Sirois
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

9.  Lack of a role for bradykinin in allergen-induced airway microvascular leakage and bronchoconstriction in the guinea pig.

Authors:  T Sakamoto; P J Barnes; K F Chung
Journal:  Inflamm Res       Date:  1996-03       Impact factor: 4.575

10.  Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs.

Authors:  F L Ricciardolo; J A Nadel; P D Graf; C Bertrand; S Yoshihara; P Geppetti
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.